Merck forecasts 2026 sales below estimates on patent losses [Yahoo! Finance Canada]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance Canada
The weaker-than-anticipated outlook overshadowed a fourth-quarter report in which the U.S. ?drugmaker beat expectations, driven by strong demand for its blockbuster cancer immunotherapy Keytruda. Shares of the drugmaker fell 1.2% in premarket trading. The company expects ?2026 revenue of $65.5 billion to $67.0 billion, with the high end of the range falling short of the average analyst estimate of $67.6 billion, according to LSEG data. "Where the disconnect is coming with the Street, frankly, is in a lot of our legacy products, and these are products that are all largely going off patent," CEO Rob Davis said in an ?interview. "As I look at the strategic ?drivers of this company, I'm actually very confident." He said the drugs that would be weaker than analysts are expecting include Januvia and related medicines Janumet and Janumet XR, as ?well as Bridion, an injection that reverses the effect of muscle-blocking drugs at the end of surgery. Analysts were already expecting sign
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck and Pfizer decline vs the broader market as results released [Yahoo! Finance]Yahoo! Finance
- Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms [MSNBC.com]MSNBC.com
- Merck's (NYSE:MRK) Q4 CY2025 Sales Beat Estimates [Yahoo! Finance]Yahoo! Finance
- China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® [Yahoo! Finance]Yahoo! Finance
- Earnings Snapshot: Merck tops Q4, issues weaker-than-expected FY profit and sales outlook [Seeking Alpha]Seeking Alpha
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 2/3/26 - Form 8-K
- 1/28/26 - Form 4
- 1/28/26 - Form 4
- MRK's page on the SEC website